Wakefit Innovations

Wakefit warned that a sharp rise in crude oil-linked input costs could weigh on margins and near-term profitability despite the recent price hikes—showing how elevated oil prices due to the Iran war-led disruptions are starting to squeeze consumer businesses beyond fuel-intensive sectors.

Here are the companies that have seen massive buying from mutual funds in the most recent March 2026 quarter.

Last week, 15 companies entered the Indian stock market, showcasing robust investor interest despite volatility. Mainboard IPOs saw strong subscriptions, and an additional 15 companies are expected to join, potentially raising December listings to nearly 50.

Wakefit Innovations IPO: After receiving 2.52 times oversubscription in its bidding rounds, the Wakefit Innovations public issue is set to hit Dalal Street on Monday, 15 December 2025. Here's what GMP experts signal about the share debut.

After receiving a moderate response during the three-day subscription period, the shares of Wakefit Solutions are trading at a premium of ₹ 7, as per Investorgain.

Upcoming IPOs: Meanwhile, Wakefit Innovations IPO, Corona Remedies IPO, Nephrocare Health IPO and others will make their stock market debut in the upcoming week.

Wakefit Innovations IPO has finalized its allotment process, with shares set to debut on December 15 on BSE and NSE. The IPO saw a 2.52 times subscription, and the grey market indicates a steady start at ₹ 195 per share.

Wakefit Innovations IPO attracted significant investor interest with allotment on December 11, 2025. Shares will list on BSE and NSE on December 15, following a successful subscription. Investors can check allotment status online, while the company raised ₹ 1,288.89 crore through the issue.